Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AMAL | AMN |
|---|---|---|
| Price | $47.73 | $36.84 |
| Change today | ▼ 0.95% | ▲ 0.57% |
| Market cap | $1.43B | $1.43B |
| Return, 3 months | +4.6% | +10.8% |
| Return, year to date | +50.8% | +133.8% |
| Return, 1 year | +76.6% | +86.2% |
| P/E (TTM) | 12.7 | 13.7 |
| P/B | 1.7 | 1.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.30% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 50 | 67 |
| 30-day volatility | 18.3% | 25.4% |
| Max drawdown, 1 year | -11.8% | -28.7% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
